Since in this TNBC cohort, the Cyr61 expression significantly correlated with several tumor-promoting biomarkers, here, the clinical relevance of the new identified uPAR-Cyr61 interaction was analyzed in more detail by a proximity ligation assay. This evidence concerns the gene CCN1 and neoplasm.